🇰🇷 South Korea Country × Condition
chronic coronary syndrome Clinical Trials in South Korea
Active clinical trials for chronic coronary syndrome with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 4 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT06742931
Recruiting
Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2
Enrollment
1,200 pts
Country
🇰🇷 South Korea
Samsung Medical Center
View Trial → NCT07471867 Phase 4
Recruiting
Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention
Enrollment
100 pts
Country
🇰🇷 South Korea
Yonsei University
View Trial → Frequently Asked Questions
How many chronic coronary syndrome clinical trials are active in South Korea?
There are currently 2 active clinical trials for chronic coronary syndrome with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a chronic coronary syndrome clinical trial in South Korea?
To join a chronic coronary syndrome clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are chronic coronary syndrome trials in South Korea?
Active chronic coronary syndrome trials in South Korea span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology